C67.5 ICD-10-CM Code: Malignant neoplasm of bladder neck
C67.5 maps to CMS-HCC V28 22 (RAF 0.363). Documentation must support MEAT. MEAT criteria · RAF calculator · free HCC coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of urinary tract (C64-C68)
C67.5
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceMalignant neoplasm of bladder neck
Cancer that starts at the bladder neck, the narrow opening where urine exits the bladder into the urethra.

Buddy Insight
Bladder neck malignancy carries unique clinical significance because this anatomical location directly affects urinary outflow and continence.
CMS-HCC V28
MappedHCC 22
RAF 0.363
CMS-HCC V24
MappedHCC 11
RAF 0.307
ACA/HHS
MappedHCC 12
Varies by metal level
ESRD/PACE
MappedHCC 11
RAF 0.059
RXHCC
MappedHCC 22
RAF 0.124
Code Book Path
Inclusion Terms
Official- Malignant neoplasm of internal urethral orifice
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for C67.5 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for C67.5 in this effective period.
Excludes 1
OfficialICD-10-CM does not list Excludes 1 notes for C67.5 in this effective period.
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for C67.5 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for C67.5 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for C67.5 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is C67.5 an HCC code?
Yes. C67.5 (Malignant neoplasm of bladder neck) maps to Bladder, Colorectal, and Other Cancers under the CMS-HCC V28 risk adjustment model (and Colorectal, Bladder, and Other Cancers under V24), with a community non-dual aged RAF of 0.363. It is billable for payment year 2026.
Coder answer: C67.5 is billable and maps to V28 HCC 22, Bladder, Colorectal, and Other Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- C67.5
- Description
- Malignant neoplasm of bladder neck
- HCC (V28)
- HCC 22 — Bladder, Colorectal, and Other Cancers
- RAF
- 0.363
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work C67.5 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for C67.5
For C67.5 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C67.5 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
C67.5 is the ICD-10-CM diagnosis code for malignant neoplasm of bladder neck. Cancer that starts at the bladder neck, the narrow opening where urine exits the bladder into the urethra. C67.5 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of urinary tract (c64-c68).
Under the CMS-HCC V28 risk adjustment model, C67.5 maps to Bladder, Colorectal, and Other Cancers (HCC 22) with a community, non-dual, aged base RAF weight of 0.363. Under the older CMS-HCC V24 model, C67.5 maps to Colorectal, Bladder, and Other Cancers (HCC 11) with a community, non-dual, aged base RAF weight of 0.307. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Bladder neck involvement affects urinary function and treatment options. Because C67.5 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C67.5 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Bladder neck involvement affects urinary function and treatment options
- •Distinguish from ureteric orifice (C67.6) which is where ureters enter the bladder
Clinical Significance
Bladder neck malignancy carries unique clinical significance because this anatomical location directly affects urinary outflow and continence. Tumors here frequently cause obstructive urinary symptoms and may require complex surgical intervention including radical cystectomy with urinary diversion, driving higher resource utilization.
Documentation Requirements
- ✓Pathology report confirming malignancy with histological type
- ✓Documentation specifying bladder neck as the tumor location (not simply 'lower bladder')
- ✓Cystoscopy or imaging confirming anatomical site
- ✓Stage and grade of tumor
- ✓Current treatment status — active, remission, or surveillance
Commonly Confused Codes
- •C67.6: Ureteric orifice: the bladder neck is where urine exits into the urethra, while the ureteric orifice is where the ureter enters the bladder; completely different anatomical locations
- •C68.0: Malignant neoplasm of urethra: bladder neck is the junction; if tumor extends into the urethra, determine the primary site
- •C67.9: Bladder, unspecified: query for bladder neck specificity when provider documents 'lower bladder tumor'

